Global Hyaluronidase Market

Hyaluronidase Market by Types (Animal-derived, and Synthetic), Applications (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1289
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 176
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global hyaluronidase market size is anticipated to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing penetration through different applications and incidence of multiple case studies to demonstrate product efficiency.

Global Hyaluronidase Market summary

Applications of hyaluronidase are ophthalmic therapeutic solutions, cosmetic treatments, and cancer therapy. Its developing role in cancer metastasis and therapy due to enzyme based substrates used for noninvasive tumor imaging is projected to propel the demand and subsequent growth of the market with lucrative avenues. The demand of cosmetics and aesthetics procedures is rising with increasing awareness about alteration of physical appearance among people. Due to easy access of advanced cosmetic treatments and growing prevalence of skin disorders the demand of hyaluronidase is rising across cosmetic dermatology.

Hyaluronidase therapy supports in dissolving subcutaneous nodules and correct excessive injected fillers. Due to this interest of professionals has increased in cosmetic industry for gaining knowledge about its adverse effects, use, and applications. In the hyaluronic acid fillers management adoption of enzyme has increased because of all these factors. Though, there are some symptoms of overdose which are sweating, vision, and confusion among others.

Hence, the beautician or practitioner should be skilled and knowledgeable with appropriate dosage of hyaluronidase including information about required remedies and possible complications. Growing advancements focuses on reducing side effects of hyaluronidase administration are anticipated to offer beneficial opportunities to the major market players.

Market Trends, Drivers, Restraints, and Opportunities

  • Growing prevalence of cancer, technological advancements, and various applications in cancer therapy are projected to fuel the market expansion over the forecast period.
  • Easy accessibility and availability of medicines made out of hyaluronidase and ophthalmic therapeutic solutions are anticipated to drive the growth of the market.
  • Globally, rising awareness among people about physical appearance is expected to push the market growth in the coming years.
  • Growing number of people opting for aesthetic nonsurgical procedures, rising geriatric population, and favorable reimbursement policies are anticipated to boost the market growth.
  • Several side effects of the product such as dizziness, rapid heartbeats, unusual weakness, and skin rashes are projected to impede the market growth over the forecast period.

Scope of the Report

The report on the global hyaluronidase market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Hyaluronidase Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Animal-derived, and Synthetic), Applications (Dermatology, Chemotherapy, Ophthalmology, Plastic Surgery, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Amphastar Pharmaceuticals, Inc., PrimaPharma, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., and Shreya Life Sciences Pvt. Ltd.


Market Segment Insights

Animal-derived segment is projected to hold a key market share

In terms of types, the hyaluronidase market is segmented into animal-derived and synthetic. The animal-derived segment is expected to hold a key share of the market in the coming years. Various commercial and approved brand are present in the market which are derived from animal sources. Though, due to limitations related to animal-derived products have encouraged the development and usage of synthetic products. The safety and quality of local anesthetic blocks has enhanced by the high efficacy of recombinant human hyaluronidase.

To make sure the correct selection of products, professional must aware about different properties of sources. While recommending therapy Practitioners must analyze the products from confirmed source to make informed decisions. The most widely used animal sources are bovine and porcine products where, synthetic products includes human recombinant sources.

Global Hyaluronidase Market types

Chemotherapy segment is expected to grow at a rapid pace

On the basis of applications, the hyaluronidase market is divided into chemotherapy, ophthalmology, plastic surgery, and others. Usage of hyaluronidase is increased majorly in medicine, to augment dispersion and absorption of other injected drugs. Hence, use of hyaluronidase is increased in chemotherapy & osteoarthritis which boosts the generation of revenue. Hence, chemotherapy segment is expected to grow at rapid space over the forecast period.

The growing incidences of hyaluronidase use in dermatology results in largest revenue generation. Establishing a standard protocol is projected to drive the market growth in coming years. Injections are employed in chemotherapy indications. Many case studies and research recommended its use to resolve extravasation. Utility as a complement in chemotherapy is related with improved tumor response to chemotherapeutic drugs.

Global Hyaluronidase Market application

Asia Pacific is expected to dominate the market

On the basis of regions, the hyaluronidase market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to occurrence of large number of dermatology clinics prescribing such treatments, presence of major players who manufactures these products, and high acceptance of advanced treatment.

However, the market of Asia Pacific is expected to exhibit a rapid growth rate in the coming years due to importance of medical tourism for dermatology treatments and chemotherapy applications in several countries. This has encouraged numerous international companies for interments in Asia Pacific. Prevalence of large number of suppliers along with advanced technology in South Korea is driving the growth of the Asian market.

Global Hyaluronidase Market region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Global Hyaluronidase Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Global Hyaluronidase Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Global Hyaluronidase Market - Supply Chain
  4.5. Global Global Hyaluronidase Market Forecast
     4.5.1. Global Hyaluronidase Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Global Hyaluronidase Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Global Hyaluronidase Market Absolute $ Opportunity
5. Global Global Hyaluronidase Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Global Hyaluronidase Market Size and Volume Forecast by Types
     5.3.1. Animal-derived Hyaluronidase
     5.3.2. Synthetic Hyaluronidase
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Global Hyaluronidase Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Global Hyaluronidase Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Global Hyaluronidase Demand Share Forecast, 2019-2026
7. North America Global Hyaluronidase Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Global Hyaluronidase Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Global Hyaluronidase Market Size and Volume Forecast by Types
     7.4.1. Animal-derived Hyaluronidase
     7.4.2. Synthetic Hyaluronidase
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Global Hyaluronidase Demand Share Forecast, 2019-2026
8. Latin America Global Hyaluronidase Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Global Hyaluronidase Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Global Hyaluronidase Market Size and Volume Forecast by Types
     8.4.1. Animal-derived Hyaluronidase
     8.4.2. Synthetic Hyaluronidase
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Global Hyaluronidase Demand Share Forecast, 2019-2026
9. Europe Global Hyaluronidase Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Global Hyaluronidase Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Global Hyaluronidase Market Size and Volume Forecast by Types
     9.4.1. Animal-derived Hyaluronidase
     9.4.2. Synthetic Hyaluronidase
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Global Hyaluronidase Demand Share Forecast, 2019-2026
10. Asia Pacific Global Hyaluronidase Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Global Hyaluronidase Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Global Hyaluronidase Market Size and Volume Forecast by Types
     10.4.1. Animal-derived Hyaluronidase
     10.4.2. Synthetic Hyaluronidase
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Global Hyaluronidase Demand Share Forecast, 2019-2026
11. Middle East & Africa Global Hyaluronidase Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Global Hyaluronidase Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Global Hyaluronidase Market Size and Volume Forecast by Types
     11.4.1. Animal-derived Hyaluronidase
     11.4.2. Synthetic Hyaluronidase
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Global Hyaluronidase Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Global Hyaluronidase Market: Market Share Analysis
  12.2. Global Hyaluronidase Distributors and Customers
  12.3. Global Hyaluronidase Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Amphastar Pharmaceuticals, Inc.
     12.4.2. PrimaPharma, Inc.
     12.4.3. Halozyme, Inc.
     12.4.4. Bausch & Lomb Incorporated
     12.4.5. The Cooper Companies Inc.
     12.4.6. Sun Pharmaceutical Industries Ltd.
     12.4.7. STEMCELL Technologies Inc.
Segments Covered in the Report
The global hyaluronidase market has been segmented on the basis of
Types
  • Animal-derived Hyaluronidase
  • Synthetic Hyaluronidase
Applications
  • Dermatology
  • Chemotherapy
  • Ophthalmology
  • Plastic Surgery
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Amphastar Pharmaceuticals, Inc.
  • PrimaPharma, Inc.
  • Halozyme, Inc.
  • Bausch & Lomb Incorporated
  • The Cooper Companies Inc.
  • Sun Pharmaceutical Industries Ltd.
  • STEMCELL Technologies Inc.
  • Shreya Life Sciences Pvt. Ltd.

Key players competing in the hyaluronidase market include Amphastar Pharmaceuticals, Inc., PrimaPharma, Inc., Halozyme, Inc., Bausch & Lomb Incorporated, The Cooper Companies Inc., Sun Pharmaceutical Industries Ltd., STEMCELL Technologies Inc., and Shreya Life Sciences Pvt. Ltd.

Major market players implement various business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. For instance, Genetech, Inc., a subsidiary of Roche Holding AG, in February 2019, received FDA approval for its product-Herceptin Hylecta.  Herceptin Hylecta is a subcutaneous injection used for treatment of breast cancer patients.

Global Hyaluronidase Market keyplayers

Buy Report